Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous Heparin for CVC Thrombosis in Infants
NCT04767113Completed
- Sponsor
- Guangdong Provincial People's Hospital
- Start
- Mar 2021
- Primary completion
- Aug 2022
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of dextrose monohydrate + heparin sodium in catheter-related thrombosis (CRT) (2 arms), sponsored by Guangdong Provincial People's Hospital. Primary endpoint: Incidence of central venous catheter-related thrombosis at 30 days. Started Mar 2021; status: completed.
02
Drugs
dextrose monohydrate + heparin sodium
03
Conditions
catheter-related thrombosis (CRT)
Beyond the preview
Go deeper on NCT04767113.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04767113.